HARVARD BIOSCIENCE INC
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| HARVARD BIOSCIENCE, INC. | ||
|---|---|---|
| Date: March 13, 2025 | By: | /s/ JAMES GREEN |
| James Green | ||
| Chief Executive Officer | ||
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ JAMES GREEN | Chief Executive Officer and Director (Principal Executive Officer) | March 13, 2025 |
| James Green | ||
| /s/ JENNIFER COTE | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | March 13, 2025 |
| Jennifer Cote | ||
| /s/ KATHERINE A. EADE | Director | March 13, 2025 |
| Katherine A. Eade | ||
| /s/ ALAN EDRICK | Director | March 13, 2025 |
| Alan Edrick | ||
| /s/ THOMAS W. LOEWALD | Director | March 13, 2025 |
| Thomas W. Loewald | ||
| /s/ BERTRAND LOY | Director | March 13, 2025 |
| Bertrand Loy | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.